SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

AGHAZADEH TABRIZI, Mojgan
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.158
EU - Europa 4.962
AS - Asia 4.915
SA - Sud America 953
AF - Africa 112
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 9
Totale 23.119
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.938
DE - Germania 2.045
SG - Singapore 1.764
CN - Cina 1.624
BR - Brasile 813
UA - Ucraina 641
RU - Federazione Russa 530
TR - Turchia 493
HK - Hong Kong 477
GB - Regno Unito 428
IT - Italia 406
FI - Finlandia 260
VN - Vietnam 259
SE - Svezia 256
CA - Canada 110
PL - Polonia 108
FR - Francia 97
MX - Messico 89
AR - Argentina 71
IN - India 56
ZA - Sudafrica 51
BD - Bangladesh 44
BE - Belgio 42
JP - Giappone 37
ID - Indonesia 28
IQ - Iraq 27
ES - Italia 24
NL - Olanda 23
CZ - Repubblica Ceca 22
LT - Lituania 20
PK - Pakistan 17
MA - Marocco 16
CO - Colombia 13
EC - Ecuador 13
AE - Emirati Arabi Uniti 12
UZ - Uzbekistan 12
AT - Austria 11
CL - Cile 11
EG - Egitto 11
KE - Kenya 11
KR - Corea 11
AU - Australia 9
IL - Israele 9
UY - Uruguay 9
EU - Europa 7
NP - Nepal 7
PY - Paraguay 7
VE - Venezuela 7
PE - Perù 6
RO - Romania 6
SA - Arabia Saudita 6
TN - Tunisia 6
BG - Bulgaria 5
DZ - Algeria 5
IE - Irlanda 4
IR - Iran 4
KZ - Kazakistan 4
MK - Macedonia 4
PT - Portogallo 4
TW - Taiwan 4
AL - Albania 3
AZ - Azerbaigian 3
BH - Bahrain 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
GR - Grecia 3
GT - Guatemala 3
LV - Lettonia 3
TH - Thailandia 3
BO - Bolivia 2
CG - Congo 2
CI - Costa d'Avorio 2
ET - Etiopia 2
HN - Honduras 2
JM - Giamaica 2
MN - Mongolia 2
MT - Malta 2
PA - Panama 2
RS - Serbia 2
SN - Senegal 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
BY - Bielorussia 1
CR - Costa Rica 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
GA - Gabon 1
GL - Groenlandia 1
GP - Guadalupe 1
GY - Guiana 1
HU - Ungheria 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
Totale 23.106
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.266
Fairfield 1.203
Singapore 1.064
Ashburn 1.024
Dallas 952
Houston 744
Jacksonville 698
Ann Arbor 684
Chandler 574
Beijing 519
Seattle 506
Wilmington 496
Santa Clara 483
Hong Kong 472
Cambridge 393
Izmir 220
Los Angeles 187
Nanjing 185
Munich 176
Ferrara 154
Princeton 145
Boardman 142
San Diego 111
New York 106
Shanghai 96
Warsaw 94
Milan 87
Ho Chi Minh City 82
São Paulo 75
Bremen 74
Helsinki 68
London 66
Hefei 65
Shenyang 61
Nanchang 59
Mexico City 56
Turku 56
Changsha 49
Tianjin 48
Hanoi 45
Hebei 44
San Mateo 43
Brussels 38
Falkenstein 38
Jiaxing 38
Montreal 37
Chicago 36
Brooklyn 35
Tokyo 34
Frankfurt am Main 32
Johannesburg 30
Dong Ket 29
Falls Church 29
Atlanta 28
Dearborn 28
Moscow 28
Jinan 27
Philadelphia 27
Toronto 27
Phoenix 26
Redwood City 25
Rio de Janeiro 24
Stockholm 24
Zhengzhou 23
Buffalo 22
Mountain View 22
Addison 21
Denver 21
Brasília 20
Kunming 20
Poplar 20
San Francisco 20
Belo Horizonte 19
Boston 19
Guangzhou 19
The Dalles 18
Orem 17
Curitiba 16
Brno 15
Chennai 15
Columbus 15
Orange 15
Ankara 14
Auburn Hills 14
Bexley 14
Hangzhou 14
Indiana 14
Jakarta 14
Washington 14
Amsterdam 12
Haiphong 12
Ningbo 12
Norwalk 12
Baghdad 11
Des Moines 11
Guarulhos 11
Manchester 11
Tappahannock 11
Bari 10
Espoo 10
Totale 14.890
Salva come PNG Salva come JPEG
Nome #
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists 1.171
Handbook of Cannabis and Related Pathologies 302
A glance at adenosine receptors: Novel target for antitumor therapy 261
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists 252
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 236
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 235
A [3+2] nitrile oxide intermolecular cycloaddition approach to 4,5-dihydro-3(2H)-furanone and 3(2H)-furanone ring systems: application to the formal synthesis of (±)-ascofuranone and geiparvarin. 232
A synthetic approach for the preparation of rigid analogs of 1,3-dipropyl-7-methyl-8-aryl/heteroarylstyryl xanthines 230
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 230
A3 adenosine receptor antagonists: History and future perspectives 230
7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: A promising approach for treating pain and inflammation 223
Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3’,4’,5’-Trimethoxyphenyl)-2-Aryl-1H-Imidazole 218
The A3 adenosine receptor: history and perspectives 216
Adenosine receptors and human melanoma 215
Allosteric modulators for the A1-adenosine receptor 214
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 212
Design, synthesis, DNA binding, and biological evaluation of water-soluble hybrid molecules containing two pyrazole analogues of the alkylating cyclopropylpyrroloindole (CPI) subunit of the antitumor agent CC-1065 and polypyrrole minor groove binders 212
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 209
Design, synthesis and in vitro cytotoxicity of a cis-dichloroplatinum(II) complex linked to the minor groove binder stallimycin 208
DNA minor groove binders as potential antitumor and antimicrobial agents 207
New 2-heterocyclyl-imidazo[2,1- i ]purin-5-one derivatives as potent and selective human A 3 adenosine receptor antagonists 205
Allosteric enhancers for A(1) adenosine receptor 204
Synthesis and biological effects of a new series of 2-amino-3-benzoylthiophenes as allosteric enhancers of A1-adenosine receptor 204
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 203
Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology into Clinical Utility 201
Pyrazole phenylcyclohexylcarbamates as inhibitors of human fatty acid amide hydrolases (FAAH) 197
Synthesis and biological evaluation of 2-and 3-aminobenzo[b]thiophene derivatives as antimitotic agents and inhibitors of tubulin polymerization 196
Blockade of A2A receptors plus L-DOPA after nigrostriatal lesion results in GAD67 mRNA changes different from L-DOPA alone in the rat globus pallidus and substantia nigra reticulata 196
Novel 8-heterocyclyl xanthine derivatives in drug development - An update 196
[H-3]-MRE 2029-F20, a selective antagonist radioligand for the human A(2B) adenosine receptors 195
Pyrazolo [4,3-e][1,2,4]triazolo[1,5-c]pyrimidine template: Organic and medicinal chemistry approach 192
Synthesis and preliminary biological evaluation of new anti-tubulin agents containing different benzoheterocycles 192
From tyrosine to glycine: Synthesis and biological activity of potent antagonists of the purinergic P2X(7) receptor 190
Hybrid molecules based on distamycin A as potential antitumor agents 190
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 188
Hybrid molecules between distamycin A and active moieties of antitumor agents 188
Geiparvarin analogs. 2. Synthesis and cytostatic activity of 5-(4-arylbutadienyl)-3(2H)-furanones and of N-substituted 3-(4-oxo-2-furanyl)-2-buten-2-yl carbamates. 187
Discovery and Optimization of a Series of 2-Aryl-4-Amino-5-(3 ',4 ',5 '-trimethoxybenzoyl)Thiazoles as Novel Anticancer Agents 187
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2 186
Synthesis and biological evaluation of 2-(3 ',4 ',5 '-trimethoxybenzoyl)-3-amino 5-aryl thiophenes as a new class of tubulin inhibitors 184
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 184
Structure-activity relationship studies of a new series of imidazo[2,1-f] purinones as potent and selective A3 adenosine receptor antagonists 183
Design, synthesis and growth inhibition activity of bis-epoxyethyl derivatives of stallimycin modified on the amidino moiety 179
Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines and linked Heterocycles as template for the adenosine receptor antagonism: Medicinal chemistry approach and sar considerations 179
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors 179
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 177
Synthesis of a new series of pyrazolo[1,5-a]pyrimidines structurally related to zaleplon 176
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists 176
Synthesis and Biological Evaluation of Novel Allosteric Enhancers of the A1 Adenosine Receptor Based on 2-Amino-3-(4’-Chlorobenzoyl)-4-Substituted-5-Arylethynyl Thiophene 176
Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease 176
Geiparvarin Analogs. 3. Synthesis and cytostatic activity of 3(2H)-furanone and 4,5-dihydro-3(2H)-furanone congeners of geiparvarin, containing a geraniol-like fragment in the side chain 175
Synthesis of conformationally constrained analogues of KN62, a potent antagonist of the P2X7-receptor 173
Microwave-assisted synthesis of thieno[2,3-c]pyridine derivatives as a new series of allosteric enhancers at the adenosine A(1) receptor 172
Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxyphenylsulfonyl)-5-aryl thiophenes as a new class of antitubulin agents 170
Structure-activity relationships around the KN-62, a potent antagonist of the P2X(7)receptor 170
Biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptors 170
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4- arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. Effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor 170
Synthesis and Biological Evaluation of 1-Methyl-2-(3’,4’,5’-Trimethoxybenzoyl)-3-Amino Indoles as a New Class of Antimitotic Agents and Tubulin Inhibitors 168
Recent developments in the field of adenosine receptor ligands. 166
Recent improvements in the development of A2B adenosine receptor agonists 166
Microwave-assisted synthesis of substituted 2,4-diarylthiazoles and their evaluation as anticancer agents 163
Hybrid molecules containing benzo[4,5]imidazo[1,2-d][1,2,4]thiadiazole and alpha-bromoacryloyl moieties as potent apoptosis inducers on human myeloid leukaemia cells 159
New 2-arylpyrazolo[4,3-c]quinoline derivatives as potent and selective human A(3) adenosine receptor antagonists 158
New pyrrolo[2,1-f]purine-2,4-dione and imidazo[2,1-f]purine-2,4-dione derivatives as potent and selective human A(3) adenosine receptor antagonists 157
Pyrazolotriazolopyrimidine derivatives sensitize melanoma cells to the chemiotherapic drugs: taxol and vindesine. 157
Recent improvements in the development of A2B adenosine receptor agonists 157
Recent developments in A2B adenosine receptor ligands 157
Synthesis, radiolabeling, and preliminary biological evaluation of [H-3]-1-[(S)-N,O-bis-(isoquinolinesulfonyl)-N-methyl-tyrosyl]-4-(o-tolyl )-piperazine, a potent antagonist radioligand for the P2X(7) receptor 156
Recent developments in the field of A(2A) and A(3) adenosine receptor antagonists 156
A structural study of new potent and selective antagonists to the A(2B) adenosine receptor 156
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 155
Blockade of globus pallidus adenosine A2A receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D 1 or D2 dopamine receptor agonists 155
New synthesis of diazepino[3,2,1-ij]quinoline and pyrido[1,2,3-de] quinoxalines via addition-elimination followed by cycloacylation 155
New 2-arylpyrazolo[4,3-c]quinoline derivates as potent and selective human A3 adenosine receptor antagonists 155
Preparation of substituted purinylpyrazolylacetamides as adenosine A2B receptor antagonists. 153
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 153
Concise Synthesis and Biological Evaluation of 2-Aroyl-5-Amino Benzo[b]thiophene Derivatives As a Novel Class of Potent Antimitotic Agents 151
Medicinal chemistry, pharmacology, and potential therapeutic benefits of cannabinoid CB2receptor agonists 151
Design, synthesis, and biological evaluation of C-9- and C-2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c] pyrimidines as new A(2A) and A(3) adenosine receptors antagonists 150
Synthesis and biological evaluation of novel N-6-[4-(substituted) sulfonamidophenylcarbamoyl]adenosine-5 '-uronamides as A(3) adenosine receptor agonists 148
New strategies for the synthesis of A(3) adenosine receptor antagonists 148
Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson's disease 147
Involvement of globus pallidus in the antiparkinsonian effects of adenosine A2A receptor antagonists 146
MODULATION OF MMP-9 IN U87MG GLIOBLASTOMA CELLS BY A3 ADENOSINE RECEPTORS 144
Structure-activity relationships of 2-amino-3-aroyl-4-[(4-arylpiperazin-1- yl)methyl]thiophenes. Part 2: Probing the influence of diverse substituents at the phenyl of the arylpiperazine moiety on allosteric enhancer activity at the A 1 adenosine receptor 143
Preparation of fused purine derivatives as adenosine A3 receptor modulators. 140
Synthesis and biological evaluation of 2-substituted-4-(3 ',4 ',5 '-trimethoxyphenyl)-5-aryl thiazoles as anticancer agents 138
Cytotoxic drugs regulate VEGF and IL-8 expression in human melanoma cells by A2A and A3 adenosine receptors. 137
Allosteric enhancers of A1 adenosine receptors: State of the art and new horizons for drug development 134
Recent developments in the field of adenosine receptor ligands 133
Preparation of fused purine derivatives as adenosine A3 receptor modulators. 133
Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine ligands, new tools to characterize A(3) adenosine receptors in human tumor cell lines 132
Ligands for A(2B) adenosine receptor subtype 131
Modulation of MMP-9 in U87MG glioblastoma cells by A3 adenosine receptors. 131
Design, synthesis and biological evaluation of hybrid molecules containing conjugated styryl ketone and α-bromoacryloyl moieties 131
Recent improvements in the field of A(3) adenosine receptor ligands 131
New pyrrolo [2,1-f] purine-2,4-dione and Imidazo[2,1-f]purine-2,4-dione derivates as potent and selective human A3 adenosine receptor antagonists 129
Role of strong intramolecular N-H...N hydrogen bonds in determining the conformation of adenosine-receptors antagonists 129
Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models. 124
null 121
Totale 18.683
Salva come PNG Salva come JPEG
Categoria #
all - tutte 92.091
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.269
Totale 94.360
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.156 0 0 0 0 0 221 55 228 43 267 210 132
2021/20221.546 58 144 147 53 98 78 79 53 57 118 150 511
2022/20231.389 142 82 26 183 291 209 58 109 171 10 67 41
2023/2024752 67 94 43 28 56 111 38 74 13 10 11 207
2024/20253.165 65 101 246 128 370 336 120 189 405 315 474 416
2025/20265.372 906 586 1.351 1.112 1.268 149 0 0 0 0 0 0
Totale 23.294